GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GtreeBNT Co Ltd (115450) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9385
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epidermolysis bullosa dermal disease. GtreeBNT offers OKN-007 for the treatment of glioblastoma brain cancer. It also produces pumps, motors, fan motors, and transformers. The company plans to conduct clinical trials in South Korea and the US. It operates offices in Seongnam and Chilgok, South Korea. GtreeBNT is headquartered in Seongnam, South Korea.

GtreeBNT Co Ltd (115450) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
Venture Financing 11
G-treeBNT Raises USD1.4 Million in Venture Financing 11
Partnerships 12
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
Licensing Agreements 14
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
Equity Offering 16
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd – Key Competitors 19
GtreeBNT Co Ltd – Key Employees 20
GtreeBNT Co Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
G-treeBNT Raises USD1.4 Million in Venture Financing 11
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd, Key Competitors 19
GtreeBNT Co Ltd, Key Employees 20
GtreeBNT Co Ltd, Other Locations 21
GtreeBNT Co Ltd, Subsidiaries 21
GtreeBNT Co Ltd, Joint Venture 21

List of Figures
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology …
  • Green Cross LabCell Corp (144510):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross LabCell Corp (GCLabCell), a subsidiary of GC Pharma, is a biotechnology company that offers biopharmaceuticals. The company’s products include specialty medicines, blood products and vaccines, generic drugs, parenteral products, and genetically-modified hemophilia A drug Greenjun …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Toyota Motor Corporation:企業の戦略・SWOT・財務分析
    Toyota Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Antero Resources Corporation (AR)-石油・ガス分野:企業M&A・提携分析
    Summary Antero Resources Corporation (Antero), formerly Antero Resources Appalachian Corporation, is an independent oil and natural gas company that carries out exploration, development, production and acquisition of natural gas, natural gas liquids (NGLs) and oil properties in the Appalachia Basin. …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hitachi Metals, Ltd.:企業の戦略・SWOT・財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務情報
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • JM Financial Private Wealth Group:企業の戦略・SWOT・財務情報
    JM Financial Private Wealth Group - Strategy, SWOT and Corporate Finance Report Summary JM Financial Private Wealth Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • RPM International Inc:企業の戦略・SWOT・財務情報
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CSL Limited:企業のM&A・事業提携・投資動向
    CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • CryoTherapeutics Gmbh-医療機器分野:企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • EnServe Group Limited:企業のM&A・事業提携・投資動向
    EnServe Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnServe Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Rada Electronic Industries Ltd.
    Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PanTheryx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PanTheryx Inc (PanTheryx) is a medical nutrition company that research, develops and commercializes nutritional ingredients. The company’s products include foods for special dietary use, dietary supplements and medical foods. Its foods for special dietary use address the dietary needs of chi …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆